Pfizer

Market Snapshot: Investors may turn defensive as fizz leaves stocks

Caution gains ground as rally ages, recovery looks spotty , MarketWatch SAN FRANCISCO (MarketWatch) -- Friday is free of indicators, though traders may react to anecdotes from the first wave of holiday shoppers on what's known...

powered by

Aurobindo to focus on formulations, expand production capacity

Aurobindo Pharma Ltd is aiming to be a $2 billion company over next three years with an increased focus on formulations and expansion in production capacities. (It ended 2008-09 with consolidated revenues of Rs 3,077

powered by

Chamber's Donohue keeps cash coming in

Apple Inc. and three other members of the U.S. Chamber of Commerce quit over the chamber's opposition to climate-change legislation. President Barack Obama denounced the Chamber for "spending millions" to kill a planned...

powered by

FDA Advisory Committee Finds Data Support The Claim That SPIRIVA(R) HandiHaler(R) Reduces COPD...

The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to...

powered by

Inaugural recipient of the Pfizer/Heart and Stroke Foundation Chair chosen

Renowned B.C. kinesiologist and heart disease researcher Dr. Scott Lear is the inaugural recipient of the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Disease Prevention Research at St. Paul's Hospital,...

powered by

FDA OKs Abilify for autism-linked irritability

PRINCETON, N.J. - The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday.

powered by

Pa. Court Mulls Class Decertification in Off-Label Drug Case

A class can't be decertified unless there are substantial changes to the facts of a case, nor can it be decertified once a partial ruling has been made as to the merits of the case, an attorney for a class suing over the...

powered by

Princeton Reacts to Pharma Contractions

Real Estate in Recovery: What Can Be Done to Prepare for a Turnaround Presented By: Schulte Roth & Zabel and GlobeSt.com The troubled real estate market has created a buyers’ market for mortgage loan portfolios, RMBS and CMBS,...

powered by

FDA Approves Intravenous Formulation Of Pfizer's Revatio® (Sildenafil) For The Treatment Of...

Revatio is the Only Treatment in Its Class with Both Oral and Intravenous Formulations Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous...

powered by

Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive...

Data Show Geodon Used as an Adjunct to Lithium or Valproate Is Effective in the Maintenance Treatment of Bipolar I Disorder Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon®...

powered by
1 2 3 4 5 next »